In the secondary meta-analysis, various analytical methods demonstrated that there was no association between 5 μg/ml increments in adiponectin level and stroke risk (RR = 1.05, 95% CI = 1.00–1.10, P = 0.069). The gene discussed is ADIPOQ; the disease is stroke disorder.